20
Fermion Oy, based in Finland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for With Fermion, start the journey of your innovative API.
One of their notable products is IRINOTECAN HYDROCHLORIDE, with a corresponding US DMF Number 20649.
Remarkably, this DMF maintains an Active status since its submission on June 29, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 14, 2013, and payment made on September 05, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II